Journal
NEUROPSYCHIATRIC DISEASE AND TREATMENT
Volume 12, Issue -, Pages 1715-1723Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/NDT.S106752
Keywords
St John's wort; selective serotonin reuptake inhibitors; depression; meta-analysis
Categories
Funding
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX 201403]
Ask authors/readers for more resources
Objective: The aim of the study was to investigate the efficacy and safety of St John's wort extract and selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression. Methods: Databases were searched for studies comparing efficacy and/or safety of St John's wort extract with SSRIs in depression from 1966 to April 2015. Stata software was used for statistical analysis. Results: Twenty-seven studies met the study entry criteria. A total of 3,126 patients with depression were included. St John's wort extract did not differ from SSRIs in clinical response, remission, and mean reduction in Hamilton Rating Scale for Depression score. St John's wort extract had a significantly lower rate of adverse events compared to SSRIs (summary relative risk: 0.77; 95% confidence interval: 0.70, 0.84, P=0.00) and had fewer withdrawals due to adverse events. St John's wort extract had superior safety in the management of patients with depression. Conclusion: Both St John's wort extract and SSRIs are effective in treating mild-to-moderate depression. St John's wort extract is safer than SSRIs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available